CLOPIGOLD A 75 Mg : MedlinePlus Drug Information.

May 07, 2024

CLOPIGOLD A 75 Mg

Clopidogrel + Aspirin CAPS

CLOPIGOLD A 75 is a combination capsule that includes Clopidogrel and Aspirin, two potent agents used in the prevention of blood clots. This medication is primarily prescribed to reduce the risk of heart attacks and strokes in persons with heart disease (including recent myocardial infarction), unstable angina, or a history of such conditions.

Composition:

Each capsule of CLOPIGOLD A 75 contains Clopidogrel and Aspirin in doses that are specifically balanced to optimize blood thinning while minimizing side effects. This combination harnesses the antiplatelet properties of both substances to prevent the formation of clots.

Uses:

CLOPIGOLD A 75 is used for:

  • Prevention of blood clots in arteries, a common cause of heart attacks and strokes.
  • Management of acute coronary syndrome.
  • Secondary prevention of cardiovascular events in patients with a history of heart disease.

Dosage:

The dosage of CLOPIGOLD A 75 should be taken as directed by a healthcare provider. Typically, it is taken once daily with a full glass of water. Patients are advised not to alter the dose or discontinue use without consulting their doctor.

Side Effects:

While effective, CLOPIGOLD A 75 can cause side effects, some of which may include:

  • Increased bruising
  • Stomach upset or pain
  • Diarrhea or constipation
  • Headache

Serious side effects like blood in the urine or stools, severe bleeding, allergic reactions, or signs of liver problems (such as dark urine, persistent nausea/vomiting, jaundice) require immediate medical attention.

Price:

The price of CLOPIGOLD A 75 can vary depending on the retail outlet and geographical location. However, it is generally available at a cost that reflects its importance in managing and preventing serious health conditions.

Precautions:

Patients should discuss their full medical history with their doctor before starting CLOPIGOLD A 75, particularly if they have had any previous issues with bleeding disorders, stomach ulcers, or kidney or liver diseases. This medication is generally not recommended during pregnancy unless clearly needed.

Conclusion:

CLOPIGOLD A 75 is an effective combination therapy used to prevent serious and often life-threatening clot-related events in individuals with cardiovascular disease. Consistent use as directed by a healthcare provider, along with regular check-ups to monitor the drug’s efficacy and side effects, is crucial for its success. Patients should be aware of the potential risks and benefits of this medication and maintain open communication with their healthcare providers to ensure safe treatment. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. gynecology, Pediatrics, Dental care, and Dermatology.The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW

SHARE WITH